The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
Published version of a preprint
Abstract
PURPOSE: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas. EXPERIMENTAL DESIGN: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors. RESULTS: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of >/=85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had >/=2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 +/- 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had >/=2 CTCs. Detection of >/=2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers. CONCLUSIONS: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While circulating tumor cells (CTCs) are considered a form of liquid biopsy, and we (31) and others (47) have reported on approaches for molecular analysis of CTCs, NSCLC patient CTCs cannot always be reliably identified (44, 48, 49).”
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Addelman, S., Box, G. E. P., Hunter, W. G., & Hunter, J. S. (1979) · Technometrics · doi:10.2307/1267766 · Cited by 6,753
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Detection and characterization of carcinoma cells in the blood
Racila, E. V., Euhus, D., Weiss, A. J., Rao, C., McConnell, J. D., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 713
Ross, A., Cooper, B., Lazarus, H. M., Mackay, W., Moss, T., Ciobanu, N., Tallman, M. S., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.bloodjournal8292605 · Cited by 487
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R. H., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 440
Brugger, W., Bross, K., Glatt, M., et al. (1994) · Blood · doi:10.1182/blood.v83.3.636.bloodjournal833636 · Cited by 357
Momburg, F., Moldenhauer, G., Hämmerling, G. J., & Möller, P. (1987) · PubMed · Cited by 328
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Borgen, E., Naume, B., Nesland, J. M., Kvalheim, G., Beiske, K., Fodstad, Ø., Diel, I., Solomayer, E., Theocharous, P., Coombes, R. C., et al. (1999) · Cytotherapy · doi:10.1080/0032472031000141283 · Cited by 263
Research works printed but not linked: 8
- Soria JC, Gauthier LR, Raymond E, et al Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-5.
- Fehm T, Sagalowsky A, Clifford E, et al Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.
- Kagan M, Howard D, Bendele T, et al A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002;25:104-10.
- Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM. Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 2002;43:734
- Allard WJ, Hayes DF, Repollet MI, et al A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients[abstract A3482]. Proc Am Soc Clin Oncol 2003;22:866
- Motulsky H. The confidence interval of counted variables. Intuitive biostatistics 1995p. 245-9. Oxford University Press New York
- Miller MC, Gross S, Allard WJ, et al Circulating tumor cells (CTCs) predict survival in patients with metastatic prostate cancer[abstract A5270]. Proc Am Assoc Cancer Res 2004;45:1215
- Cristofanilli M, Reuben JM, Fritsche HA, et al Circulating tumor cells (CTCs): a novel prognostic factor for newly diagnosed metastatic breast cancer (MBC)[abstract A1349]. Proc Am Assoc Cancer Res 2003;44:1349
Cited by
Sorted by citations
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V. D., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S. R., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,595
Bono, J. S. D., Scher, H. I., Montgomery, B., Parker, C. C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. M. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,189
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,985
Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E. P., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,876
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Riethdorf, S., Fritsche, H. A., Müller, V., Rau, T., Schindlbeck, C., Rack, B. K., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,365
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,134
Sturgeon, C. M., Duffy, M. J., Stenman, U., Lilja, H. G., Brünner, N., Chan, D. W., Babaian, R. J., Bast, R. C., Dowell, B. L., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,140
Circulating tumor cells: approaches to isolation and characterization
Yu, M., Stott, S. L., Toner, M., Maheswaran, S., & Haber, D. A. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201010021 · Cited by 1,101
Emre Özkumur, A., Shah, A. M., Ciciliano, J. C., Emmink, B. L., Miyamoto, D. T., Brachtel, E. F., Yu, M., Chen, P.-I., Morgan, B., Trautwein, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005616 · Cited by 1,100
Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V., & Terstappen, L. W. M. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2821 · Cited by 1,032
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Circulating tumor cells: biology and clinical significance
Lin, D., Shen, L., Luo, M., Zhang, K., Li, J., Yang, Q., Zhu, F., Zhou, D., Zheng, S. S., Chen, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00817-8 · Cited by 1,046
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Bréchot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 953
Long-term patient survival in ANCA-associated vasculitis
Floßmann, O., Berden, A. E., de Groot, K., Hagen, C., Harper, L., Heijl, C., Höglund, P., Jayne, D. R. W., Luqmani, R. A., Mahr, A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137778 · Cited by 940
Krebs, M., Sloane, R. A. S., Priest, L. J. C., Lancashire, L., Hou, J., Greystoke, A., Ward, T. H., Ferraldeschi, R., Hughes, A. M., Clack, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7045 · Cited by 884
Hou, J., Krebs, M., Lancashire, L., Sloane, R. A. S., Backen, A. C., Swain, R. K., Priest, L. J. C., Greystoke, A., Zhou, C., Morris, K. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3716 · Cited by 844
Bidard, F., Peeters, D. J. E., Fehm, T. N., Nolè, F., Gisbert‐Criado, R., Mavroudis, D., Grisanti, S., Generali, D., García-Sáenz, J. Á., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 842
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Budd, G. T., Cristofanilli, M., Ellis, M. J., Stopeck, A., Borden, E. C., Miller, M. C., Matera, J., Repollet, M., Doyle, G. V., Terstappen, L. W. M. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1769 · Cited by 781
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
Karabacak, M., Spuhler, P. S., Fachin, F., Lim, E. J., Pai, V., Emre Özkumur, A., Martel, J. M., Kojić, N., Smith, K., Chen, P.-I., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.044 · Cited by 767
Miller, M. C., Doyle, G. V., & Terstappen, L. W. M. M. (2009) · Journal of Oncology · doi:10.1155/2010/617421 · Cited by 752
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 820
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 710
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Hodgkinson, C. L., Morrow, C. J., Li, Y., Metcalf, R. L., Rothwell, D. G., Trapani, F., Polański, R., Burt, D. J., Simpson, K., Morris, K. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3600 · Cited by 695
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
Danila, D. C., Heller, G., Gignac, G. A., Gonzalez-Espinoza, R., Anand, A., Tanaka, E., Lilja, H. G., Schwartz, L. B., Larson, S. M., Fleisher, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1506 · Cited by 665
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Smerage, J. B., Barlow, W. E., Hortobágyi, G. N., Winer, E. P., Leyland-Jones, B. R., Srkalović, G., Tejwani, S., Schott, A. F., O’Rourke, M. A., Lew, D. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2561 · Cited by 649
Tie, J., Kinde, I., Wang, Y., Wong, H., Roebert, J. K., Christie, M., TACEY, M. A., Wong, R., Singh, M., Karapetis, C. S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv177 · Cited by 632
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 638
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
Rack, B., Schindlbeck, C., Jückstock, J., Andergassen, U., Hepp, P., Zwingers, T., Friedl, T. W. P., Lorenz, R., Tesch, H., Fasching, P. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju066 · Cited by 615
“Nevertheless, the CellSearch system has shown highly reproducible and automated detection of CTCs in interlab validation trials (34,35).”
MethodScher, H. I., Jia, X., Bono, J. S. D., Fleisher, M., Pienta, K. J., Raghavan, D., & Heller, G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70340-1 · Cited by 611
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells
Warkiani, M. E., Guan, G., Luan, K. B., Lee, W. C., Bhagat, A. A. S., Chaudhuri, P. K., Tan, D. S.-W., Lim, C. T., Lee, S. C., Chen, P. C. Y., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50617g · Cited by 572
Tumor Heterogeneity in Breast Cancer
Turashvili, G., & Brogi, E. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00227 · Cited by 571
The biology of circulating tumor cells
Pantel, K., & Speicher, M. R. (2015) · Oncogene · doi:10.1038/onc.2015.192 · Cited by 556
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Lohr, J. G., Adalsteinsson, V. A., Cibulskis, K., Choudhury, A. D., Rosenberg, M. W., Cruz‐Gordillo, P., Francis, J. M., Zhang, C.-Z., Shalek, A. K., Satija, R., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2892 · Cited by 542
Powell, A. A., Talasaz, A. H., Zhang, H., Coram, M., Reddy, A., Deng, G. Y., Telli, M. L., Advani, R. H., Carlson, R. W., Mollick, J. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033788 · Cited by 539
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N., Picus, J., Morse, M. A., Mitchell, E. P., Miller, M. C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn786 · Cited by 513
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 526
Three‐Dimensional Nanostructured Substrates toward Efficient Capture of Circulating Tumor Cells
Wang, S., Wang, H., Jiao, J., Chen, K., Owens, G. E., Kamei, K., Sun, J., Sherman, D. J., Behrenbruch, C. P., Wu, H., et al. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901668 · Cited by 512
Eyles, J., Puaux, A.-L., Wang, X., Toh, B., Prakash, C., Hong, M., Tan, T. G., Zheng, L., Ong, L. C., Jin, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42002 · Cited by 506
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Lucci, A., Hall, C. S., Lodhi, A., Bhattacharyya, A., Anderson, A. E., Xiao, L., Bedrosian, I., Kuerer, H. M., & Krishnamurthy, S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70209-7 · Cited by 514
Riethdorf, S., Müller, V., Zhang, L., Rau, T., Loibl, S., Komor, M., Roller, M., Huober, J., Fehm, T. N., Schrader, I., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2042 · Cited by 489
Talasaz, A. H., Powell, A. A., Huber, D. E., Berbee, J. G., Roh, K., Yu, W., Xiao, W., Davis, M. M., Pease, R. F. W., Mindrinos, M. N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813188106 · Cited by 491
Biomarkers of gastric cancer: Current topics and future perspective
Matsuoka, T., & Yashiro, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i26.2818 · Cited by 488
Krebs, M. G., Hou, J.-M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823c5c16 · Cited by 463
A conduit to metastasis: circulating tumor cell biologyPreprint
Micalizzi, D. S., Maheswaran, S., & Haber, D. A. (2017) · Genes & Development · doi:10.1101/gad.305805.117 · Cited by 458
Marrugo-Ramírez, J., Mir, M., & Samitier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102877 · Cited by 456
Moon, H.-S., Kwon, K., Kim, S. I., Han, H., Sohn, J., Lee, S. H., & Jung, H. (2011) · Lab on a Chip · doi:10.1039/c0lc00345j · Cited by 438
Recent advances in gastric cancer early diagnosis
Necula, L. G., Matei, L., Dragu, D., Neagu, A. I., Mambet, C., Nedeianu, S., Bleoţu, C., Diaconu, C. C., & Chivu‐Economescu, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2029 · Cited by 440
Sieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P., Elstrodt, F., Schutte, M. E. M., Martens, J. W. M., Gratama, J.-W. C., Sleijfer, S., & Foekens, J. A. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn419 · Cited by 433
Cellular Image Analysis and Imaging by Flow Cytometry
Basiji, D. A., Ortyn, W. E., Liang, L., Vidya Venkatachalam, A., & Morrissey, P. (2007) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2007.05.008 · Cited by 427
3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood
Zheng, S., Lin, H. K., Lü, B., Williams, A. J., Datar, R. H., Côté, R. J., & Tai, Y. (2010) · Biomedical Microdevices · doi:10.1007/s10544-010-9485-3 · Cited by 427
Punnoose, E. A., Atwal, S., Liu, W., Raja, R., Fine, B. M., Hughes, B. G. M., Hicks, R. J., Hampton, G. M., Amler, L. C., Pirzkall, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3148 · Cited by 415
Danila, D. C., Morris, M. J., de Bono, J. S., Ryan, C. J., Denmeade, S. R., Smith, M. R., Taplin, M.-E., Bubley, G. J., Kheoh, T., Haqq, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9259 · Cited by 410
Farace, F., Massard, C., Vimond, N., Drusch, F., Jacques, N., Billiot, F., Laplanche, A., Chauchereau, A., Lacroix, L., Planchard, D., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.294 · Cited by 423
Sun, Y., Xu, Y., Yang, X., Guo, W., Zhang, X., Qiu, S., Shi, R.-Y., Hu, B., Zhou, J., & Fan, J. (2012) · Hepatology · doi:10.1002/hep.26151 · Cited by 410
Microchip-based immunomagnetic detection of circulating tumor cells
Hoshino, K., Huang, Y.-Y., Lane, N., Huebschman, M., Uhr, J. W., Frenkel, E. P., & Zhang, X. (2011) · Lab on a Chip · doi:10.1039/c1lc20270g · Cited by 400
Self-citationKelley, S. O., Mirkin, C. A., Walt, D. R., Ismagilov, R. F., Toner, M., & Sargent, E. H. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.261 · Cited by 398
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
Sethi, N. S., & Kang, Y. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3125 · Cited by 405
Reid, A. H. M., Attard, G., Danila, D. C., Oommen, N. B., Olmos, D., Fong, P. C., Molife, L. R., Hunt, J., Messiou, C., Parker, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6819 · Cited by 394
Self-citationGleghorn, J. P., Pratt, E. D., Denning, D., Liu, H., Bander, N. H., Tagawa, S. T., Nanus, D. M., Giannakakou, P., & Kirby, B. J. (2009) · Lab on a Chip · doi:10.1039/b917959c · Cited by 396
Single Cell Isolation and Analysis
Hu, P., Zhang, W., Xin, H., & Deng, G. Y. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00116 · Cited by 401
Gupta, V., Jafferji, I., Garza, M., Melnikova, V. O., Hasegawa, D. K., Pethig, R., & Davis, D. W. (2012) · Biomicrofluidics · doi:10.1063/1.4731647 · Cited by 398
A new device for rapid isolation by size and characterization of rare circulating tumor cells.
Desitter, I., Guerrouahen, B. S., Benali-Furet, N., Wechsler, J., Janne, P. A., Kuang, Y., Yanagita, M., Wang, L., Berkowitz, J. A., Distel, R. J., et al. (2011) · PubMed · Cited by 375
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Sarker, D., Reid, A. H. M., Yap, T. A., & de Bono, J. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0125 · Cited by 366
Pierga, J., Bidard, F., Mathiot, C., Brain, E. G. C., Delaloge, S., Giachetti, S., de Crémoux, P., Salmon, R. J., Vincent‐Salomon, A., & Marty, M. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0030 · Cited by 369
Lecharpentier, A., Vielh, P. R., Perez-Moreno, P., Planchard, D., Soria, J., & Farace, F. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.405 · Cited by 380
Challenges in circulating tumor cell detection by the CellSearch system
Andree, K., van Dalum, G., & Terstappen, L. W. M. M. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.002 · Cited by 378
Microdevice for the isolation and enumeration of cancer cells from blood
Tan, S. J., Yobaş, L., Lee, G. Y. H., Ong, C. N., & Lim, C. T. (2009) · Biomedical Microdevices · doi:10.1007/s10544-009-9305-9 · Cited by 363
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Janni, W., Rack, B. K., Terstappen, L. W. M. M., Pierga, J., Taran, F., Fehm, T. N., Hall, C. S., de Groot, M. R., Bidard, F., Friedl, T. W. P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1603 · Cited by 363
Technologies for circulating tumor cell separation from whole blood
Bankó, P., Lee, S. Y., Nagygyörgy, V., Zrínyi, M., Chae, C. H., Cho, D. H., & Telekes, A. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0735-4 · Cited by 358
Microfluidic, Label-Free Enrichment of Prostate Cancer Cells in Blood Based on Acoustophoresis
Augustsson, P., Magnusson, C., Antfolk, M., Lilja, H. G., & Laurell, T. (2012) · Analytical Chemistry · doi:10.1021/ac301723s · Cited by 352
Detecting Circulating Tumor Cells: Current Challenges and New Trends
Hong, B., & Zu, Y. (2013) · Theranostics · doi:10.7150/thno.5195 · Cited by 352
Xu, H., Aguilar, Z. P., Yang, L., Kuang, M., Duan, H., Xiong, Y., Wei, H., & Wang, A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.076 · Cited by 381
Size-Selective Microcavity Array for Rapid and Efficient Detection of Circulating Tumor Cells
Hosokawa, M., Hayata, T., Fukuda, Y., Arakaki, A., Yoshino, T., Tanaka, T., & Matsunaga, T. (2010) · Analytical Chemistry · doi:10.1021/ac101222x · Cited by 346
Prognostic and Predictive Biomarkers in Gliomas
Śledzińska, P., Bebyn, M. G., Furtak, J., Kowalewski, J., & Lewandowska, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910373 · Cited by 363
Ahn, J. C., Teng, P., Chen, P., Posadas, E. M., Tseng, H., Lu, S. C.-L., & Yang, J. D. (2020) · Hepatology · doi:10.1002/hep.31165 · Cited by 347
Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays
Saliba, A., Saïas, L., Psychari, E., Minc, N., Simon, D., Bidard, F., Mathiot, C., Pierga, J., Fraisier, V., Salamero, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001515107 · Cited by 338
Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer
Shaffer, D. R., Leversha, M. A., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Gu, B., Anand, A., Smith, K., Maslak, P. G., Doyle, G. V., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2701 · Cited by 338
Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer
Tanaka, F., Yoneda, K., Kondo, N., Hashimoto, M., Takuwa, T., Matsumoto, S., Okumura, Y., Rahman, S., Tsubota, N., Tsujimura, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1095 · Cited by 338
Zhang, N., Deng, Y., Tai, Q., Cheng, B., Zhao, L., Shen, Q., He, R., Hong, L., Liu, W., Guo, S., et al. (2012) · Advanced Materials · doi:10.1002/adma.201200155 · Cited by 334
Biology, vulnerabilities and clinical applications of circulating tumour cells
Ring, A., Nguyen-Sträuli, B. D., WICKI, A. N., & Aceto, N. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00536-4 · Cited by 344
Global Gene Expression Profiling of Circulating Tumor Cells
Smirnov, D. A., Zweitzig, D. R., Foulk, B. W., Miller, M. C., Doyle, G. V., Pienta, K. J., Meropol, N. J., Weiner, L. M., Cohen, S. J., Moreno, J. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4330 · Cited by 330
Thompson, J. C., Yee, S. S., Troxel, A. B., Savitch, S. L., Fan, R., Balli, D., Lieberman, D. B., Morrissette, J. D., Evans, T. L., Bauml, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1231 · Cited by 325
“While circulating tumor cells (CTC) are considered a form of liquid biopsy, and we (31) and others (47) have reported on the approaches for molecular analysis of CTCs, NSCLC patient CTCs cannot always be reliably identified (44, 48, 49).”
BackgroundConsiderations in the development of circulating tumor cell technology for clinical use
Parkinson, D. R., Dracopoli, N. C., Petty, B. G., Compton, C. C., Cristofanilli, M., Deisseroth, A., Hayes, D. F., Kapke, G. F., Kumar, P. K. M., Lee, J. S. H., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-138 · Cited by 331
Goldkorn, A., Ely, B., Quinn, D. I., Tangen, C. M., Fink, L. M., Xu, T., Twardowski, P. W., Veldhuizen, P. J. V., Agarwal, N., Carducci, M. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.7417 · Cited by 321
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Liu, M., Shields, P. G., Warren, R. D., Cohen, P., Wilkinson, M. J., Ottaviano, Y. L., Rao, S. B., Eng‐Wong, J., Seillier‐Moiseiwitsch, F., Noone, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6664 · Cited by 319
Cancer genomics: one cell at a time
Navin, N. E. (2014) · Genome biology · doi:10.1186/s13059-014-0452-9 · Cited by 318
Circulating tumor cells: a window into cancer biology and metastasis
Maheswaran, S., & Haber, D. A. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.12.002 · Cited by 322
Fundamentals and application of magnetic particles in cell isolation and enrichment: a review
Plouffe, B. D., Murthy, S. K., & Lewis, L. H. (2015) · Reports on Progress in Physics · doi:10.1088/0034-4885/78/1/016601 · Cited by 334
cke, K. L. ⁄. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1557 · Cited by 318
Review: Biological relevance of disseminated tumor cells in cancer patients
Riethdorf, S., Wikman, H., & Pantel, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23825 · Cited by 310
Hepatocellular carcinoma: old friends and new tricks
Kim, E., & Viatour, P. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00527-1 · Cited by 316
Hofman, V., Ilié, M., Long-Mira, É., Selva, É., Bonnetaud, C., Molina, T. J., Vénissac, N., Mouroux, J., Vielh, P. R., & Hofman, P. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25819 · Cited by 319
Qi, L., Xiang, B., Wu, F., Ye, J., Zhong, J., Wang, Y., Chen, Y., Chen, Z.-S., Ma, L., Chen, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2459 · Cited by 304
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Marrinucci, D. C., Bethel, K. J., Kolatkar, A. R., Luttgen, M. S., Malchiodi, M., Baehring, F., Voigt, K., Lazar, D. C., Nieva, J. J., Bazhenova, L. A., et al. (2012) · Physical Biology · doi:10.1088/1478-3975/9/1/016003 · Cited by 307
The detection of EpCAM+ and EpCAM– circulating tumor cells
de Wit, S., van Dalum, G., Lenferink, A. T. M., Tibbe, A. G. J., Hiltermann, T. J. N., Groen, H. J. M., van Rijn, C. J. M., & Terstappen, L. W. M. M. (2015) · Scientific Reports · doi:10.1038/srep12270 · Cited by 294
Molecular Biomarker Analyses Using Circulating Tumor Cells
Punnoose, E. A., Atwal, S. K., Spoerke, J. M., Savage, H. M., Pandita, A., Yeh, R., Pirzkall, A., Fine, B. M., Amler, L. C., Chen, D. S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012517 · Cited by 298
Double spiral microchannel for label-free tumor cell separation and enrichment
Sun, J., Li, M., Liu, C., Zhang, Y., Liu, D., Liu, W., Hu, G., & Jiang, X. (2012) · Lab on a Chip · doi:10.1039/c2lc40679a · Cited by 293
Scully, O. J., Bay, B., Yip, G., & Yu, Y. (1926) · The American Journal of Surgery · doi:10.1016/s0002-9610(26)90068-8 · Cited by 294
Metadata
- Authors
- Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M.
- Affiliations
- 1Immunicon Corporation, Huntingdon Valley, Pennsylvania; and
- The University of Texas Southwestern Medical Center (US)
- Venue
- Clinical Cancer Research
- Published
- 2004-10-15
- Volume
- 10
- Issue
- 20
- Pages
- 6897-6904
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2116483002
- Cited by
- 2,542
- References
- 30
- Citations by year
- 2026: 66 · 2025: 81 · 2024: 87 · 2023: 135 · 2022: 117 · 2021: 158 · 2020: 169 · 2019: 166 · 2018: 171 · 2017: 193 · 2016: 197 · 2015: 165 · 2014: 177 · 2013: 161 · 2012: 132
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Keywords
- circulating tumor cells, CellSearch, metastatic carcinoma, prostate cancer, breast cancer, ovarian cancer, colorectal cancer, lung cancer, liquid biopsy
- MeSH terms
- Adult, Automation, Biological Assay, Carcinoma, Cytological Techniques, Female, Humans, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Metastasis, Sensitivity and Specificity, Reproducibility of Results, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review